PTC
FBRX icon

Private Trust Company’s Forte Biosciences FBRX Stock Holding History

Private Trust Company’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-274
Closed -$4.11K – 2577
2025
Q3 		$4.11K Buy
274
+82
+43% +$944 ﹤0.01% 2205
2025
Q2 		$2.48K Buy
192
+150
+357% +$1.29K ﹤0.01% 2223
2025
Q1 		$326 Hold
42
– – ﹤0.01% 2435
2024
Q4 		$954 Buy
+42
New +$500 ﹤0.01% 2242

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Private Trust Company's FBRX Position: Q4 2025 in Review

Private Trust Company sold out of Forte Biosciences (FBRX) in Q4 2025, closing a stake of 274 shares — an estimated $4.11K sold.

Private Trust Company first reported a position in FBRX in Q4 2024 and held it in 4 quarters. The position peaked at $4.11K in Q3 2025. 59 funds tracked by Wall St. Rank hold FBRX as of Q4 2025.

  • Private Trust Company reported no remaining Forte Biosciences position as of Q4 2025 after selling out during the quarter.
  • Private Trust Company sold 274 Forte Biosciences shares in Q4 2025, an estimated $4.11K.
  • Private Trust Company first reported a position in Forte Biosciences in Q4 2024 and held it in 4 quarters.
  • Private Trust Company's Forte Biosciences position peaked at $4.11K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.